# Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer

> **NCT04790305** · PHASE4 · RECRUITING · sponsor: **Fudan University** · enrollment: 1072 (estimated)

## Conditions studied

- Carcinoma Breast
- Triple-negative Breast Cancer
- Invasive Ductal Carcinoma, Breast

## Interventions

- **DRUG:** Huaier Granule

## Key facts

- **NCT ID:** NCT04790305
- **Lead sponsor:** Fudan University
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-06-18
- **Primary completion:** 2027-12-31
- **Final completion:** 2028-07-28
- **Target enrollment:** 1072 (ESTIMATED)
- **Last updated:** 2024-06-27

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04790305

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04790305, "Effect of Huaier Granule on Adjuvant Treatment for High-risk Early-stage Triple-negative Breast Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT04790305. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*